Ovarian Cysts in Emergency Medicine Follow-up

  • Author: Walter W Valesky Jr; Chief Editor: Pamela L Dyne, MD   more...
 
Updated: Jul 19, 2010
 

Further Outpatient Care

Timing of outpatient care of ovarian cysts depends on the patient’s age and pregnancy status.

  • In pregnant patients, most ovarian cysts resolve at 16-20 weeks’ gestation.
    • Patients with benign-appearing ovarian cysts that are unilocular and smaller than 5-6 cm in diameter require no further follow-up for the cyst during pregnancy and require only routine prenatal visits.
    • If the cyst is larger than 5-6 cm or is multicystic, the patient should undergo follow-up ultrasonography at 16 weeks' gestation to allow time for cyst resolution. Persistent complex masses may be further characterized by MRI, either during or after pregnancy, to search for distinctive features that would guide diagnosis.[6]
    • Ovarian cysts that are strongly suggestive of malignancy or that are larger than 8-10 cm in diameter, are symptomatic, or are at an increased risk for torsion, cyst rupture, or obstruction of labor are more likely to require surgical intervention[17] and necessitate more urgent follow-up with an obstetrician and, possibly, a multidisciplinary approach in a timely fashion. If surgery is required, it is most advantageous to perform it in the early second trimester, as the risk of spontaneous abortion during this period is lower than in the first trimester. Surgical intervention is better to avoid during the third trimester, if possible, to prevent inducing preterm delivery and to avoid technical issues in dealing with a larger uterus.
  • In postpartum patients, the size and complexity of the ovarian cyst and the CA-125 level are used to determine management. Unilocular cysts smaller than 5 cm in diameter should be monitored with transvaginal ultrasonography and CA-125 studies at 6-month intervals. Complex ovarian cysts that are smaller than 5 cm in diameter in the presence of normal CA-125 levels (defined as < 35-65 U/mL) should be monitored in 4 weeks with repeat ultrasonography and CA-125 studies. Surgery may be indicated for complex ovarian tumors smaller than 5 cm in diameter when CA-125 levels are elevated (>35-65 U/mL) and for complex tumors larger than 5 cm in diameter.[15]
  • In nonpregnant premenopausal patients, various studies have examined cyst resolution with various time frames being used as indices for cyst resolution. Most of these studies showed cyst resolution by 2-3 months, dictating ultrasonography with or without gynecological follow-up in these patients.[18]
Next

Inpatient & Outpatient Medications

Epidemiological studies from the 1970s-1990s reported inverse relationships between oral contraceptive pill (OCP) use and surgically confirmed functional ovarian cysts. Short-term treatment with OCPs was thus used for initial management of ovarian cysts. However, recent meta-analyses have shown that there is no difference between OCP use and placebo in terms of treatment outcomes in ovarian cysts and that these masses should be monitored expectantly for several menstrual cycles. If a cystic mass does not resolve after this time frame, it is unlikely to be a functional cyst, and further workup may be indicated.[18]

Previous
Next

Transfer

  • When a female patient presents with abdominal pain and signs or symptoms of an intraperitoneal process of unclear etiology, transfer is indicated if any of the following conditions are met:
    • Backup surgical, obstetric, or gynecologic support is not available to the ED.
    • Operative capacity is not available at the health care delivery site.
    • Imaging capacity is not available at the facility.
  • Unstable patients should not be transferred unless the facility is truly unable to provide appropriate treatment or evaluation. The patient is the responsibility of the transferring physician until arrival at the next hospital.
Previous
Next

Complications

  • Ovarian cysts have a broad range of potential outcomes. In most cases, the cyst is benign and asymptomatic, requires no further management, and will resolve on its own. In other cases, ovarian cyst–related accidents, such as rupture and hemorrhage or torsion, occur.
  • Ovarian torsion involves the rotation of the ovarian vascular pedicle, causing obstruction to venous and, eventually, arterial flow that can lead to infarction. Most torsion cases occur in premenopausal females of child-bearing age, but up to 17% of cases affect prepubertal and postmenopausal women. It is also strongly associated with ovarian stimulation and polycystic ovarian syndrome. Ovarian torsion is more common on the right side owing to the sigmoid colon restricting the mobility of the left ovary. Malignancy may be seen in up to 2% of cases of ovarian torsion. The most common ovarian mass associated with torsion is a dermoid cyst. CT scanning and ultrasonography can assist with diagnosis. Treatment consists of laparoscopic detorsion and adnexal preservation in premenopausal women and bilateral oophorectomy in postmenopausal women.
  • Ovarian cyst rupture commonly occurs with corpus luteal cysts. They involve the right ovary in two thirds of cases and usually occur on days 20-26 of the woman’s menstrual cycle. Mittelschmerz is a form of physiological cyst rupture. In pregnant women, hemorrhagic corpus luteal cysts are usually seen in the first trimester, with most resolving by 12 weeks' gestation. Hemorrhage and shock may occur and may present late in the symptomatology.
  • In ovarian cyst rupture, ultrasonography may demonstrate free fluid in the pouch of Douglas in 40% of cases. Cyst rupture and hemorrhage may be treated conservatively with observation if the patient is stable, with follow-up scanning in 6 weeks to confirm hemorrhage resolution. Laparoscopy is indicated in hemodynamic compromise, possibility of torsion, no relief of symptoms within 48 hours, or increasing hemoperitoneum or falling hemoglobin concentration.
  • Malignancy is also among the differential diagnoses of ovarian cysts. While not an ED diagnosis, appropriate follow-up must be available to ensure resolution of cyst, or further evaluation must be undertaken.[3]
Previous
Next

Prognosis

  • The prognosis of ovarian cysts varies depending on the patient’s age and pregnancy status. Overall, 70%-80% of follicular cysts resolve spontaneously. Malignancy is a common concern among patients with ovarian cysts. Pregnant patients with simple cysts smaller than 6 cm in diameter have a malignancy risk of less than 1%. Most of these cysts resolve by 16-20 weeks' gestation, with 96% of these masses resolving spontaneously.[19] In postmenopausal patients with unilocular cysts, malignancy develops in 0.3% of cases. In complex multiloculated cysts, the risk of malignancy climbs to 36%. If cancer is diagnosed, regional or distant spread may be present in up to 70% of cases, and only 25% of new cases will be limited to stage I disease.[15]
  • Ovarian cysts larger than 4 cm in diameter have been shown to have a torsion rate of approximately 15%. Ovarian function may be preserved with laparoscopic detorsion in 90% of cases.
  • The outcome of ovarian cyst rupture is evaluated based on associated symptoms and will dictate whether patient may be discharged or admitted for laparoscopy.
Previous
Next

Patient Education

For patient education resources, visit the eMedicine Women's Health Center and Cancer and Tumors Center; also, see the patient education articles Ovarian Cysts and Ovarian Cancer.

Previous
 
Contributor Information and Disclosures
Author

Walter W Valesky Jr  MD, Clinical Assistant Instructor, Department of Emergency Medicine, State University of New York Downstate, Brooklyn

Disclosure: Nothing to disclose.

Coauthor(s)

Mark A Silverberg, MD, FACEP, MMB  Assistant Professor, Assistant Residency Director, Department of Emergency Medicine, State University of New York Downstate College of Medicine; Consulting Staff, Department of Emergency Medicine, Staten Island University Hospital, Kings County Hospital, University Hospital, State University of New York Downstate at Brooklyn

Mark A Silverberg, MD, FACEP, MMB is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, Council of Emergency Medicine Residency Directors, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Andrew A Aronson, MD, FACEP  Vice President, Physician Practices, Bravo Health Advanced Care Center; Consulting Staff, Department of Emergency Medicine, Taylor Hospital, Ridley Park, Pennsylvania

Andrew A Aronson, MD, FACEP is a member of the following medical societies: American College of Emergency Physicians, Massachusetts Medical Society, and Society of Hospital Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Dana A Stearns, MD  Assistant Director of Undergraduate Education, Department of Emergency Medicine, Massachusetts General Hospital

Dana A Stearns, MD is a member of the following medical societies: American Academy of Emergency Medicine and American College of Emergency Physicians

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Senior Pharmacy Editor, eMedicine

Disclosure: eMedicine Salary Employment

Mark Zwanger, MD, MBA  Assistant Professor, Department of Emergency Medicine, Thomas Jefferson University

Mark Zwanger, MD, MBA is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, and American Medical Association

Disclosure: Nothing to disclose.

John D Halamka, MD, MS  Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center

John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Chief Editor

Pamela L Dyne, MD  Professor of Clinical Medicine/Emergency Medicine, David Geffen School of Medicine at UCLA; Attending Physician, Department of Emergency Medicine, Olive View-UCLA Medical Center

Pamela L Dyne, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

References
  1. Katz. Comprehensive Gynecology. 5th ed. 2007.

  2. Stany MP, Hamilton CA. Benign disorders of the ovary. Obstet Gynecol Clin North Am. Jun 2008;35(2):271-84, ix. [Medline].

  3. Bottomley C, Bourne T. Diagnosis and management of ovarian cyst accidents. Best Pract Res Clin Obstet Gynaecol. Mar 17 2009;[Medline].

  4. Schmeler KM, Mayo-Smith WW, Peipert JF, Weitzen S, Manuel MD, Gordinier ME. Adnexal masses in pregnancy: surgery compared with observation. Obstet Gynecol. May 2005;105(5 Pt 1):1098-103. [Medline].

  5. Kwak DW, Sohn YS, Kim SK, Kim IK, Park YW, Kim YH. Clinical experiences of fetal ovarian cyst: diagnosis and consequence. J Korean Med Sci. Aug 2006;21(4):690-4. [Medline].

  6. Glanc P, Salem S, Farine D. Adnexal masses in the pregnant patient: a diagnostic and management challenge. Ultrasound Q. Dec 2008;24(4):225-40. [Medline].

  7. Lambert MJ, Villa M. Gynecologic ultrasound in emergency medicine. Emerg Med Clin North Am. Aug 2004;22(3):683-96. [Medline].

  8. Castillo G, Alcazar JL, Jurado M. Natural history of sonographically detected simple unilocular adnexal cysts in asymptomatic postmenopausal women. Gynecol Oncol. Mar 2004;92(3):965-9. [Medline].

  9. Heling KS, Chaoui R, Kirchmair F, Stadie S, Bollmann R. Fetal ovarian cysts: prenatal diagnosis, management and postnatal outcome. Ultrasound Obstet Gynecol. Jul 2002;20(1):47-50. [Medline].

  10. Wyshak G, Frisch RE, Albright TE, Albright NL, Schiff I. Smoking and cysts of the ovary. Int J Fertil. Nov-Dec 1988;33(6):398-404. [Medline].

  11. Holt VL, Cushing-Haugen KL, Daling JR. Risk of functional ovarian cyst: effects of smoking and marijuana use according to body mass index. Am J Epidemiol. Mar 15 2005;161(6):520-5. [Medline].

  12. Holt VL, Cushing-Haugen KL, Daling JR. Oral contraceptives, tubal sterilization, and functional ovarian cyst risk. Obstet Gynecol. Aug 2003;102(2):252-8. [Medline].

  13. Knight JA, Lesosky M, Blackmore KM, Voigt LF, Holt VL, Bernstein L, et al. Ovarian cysts and breast cancer: results from the Women's Contraceptive and Reproductive Experiences Study. Breast Cancer Res Treat. May 2008;109(1):157-64. [Medline].

  14. Bosetti C, Scotti L, Negri E, Talamini R, Levi F, Franceschi S. Benign ovarian cysts and breast cancer risk. Int J Cancer. Oct 1 2006;119(7):1679-82. [Medline].

  15. McDonald JM, Modesitt SC. The incidental postmenopausal adnexal mass. Clin Obstet Gynecol. Sep 2006;49(3):506-16. [Medline].

  16. Vandermeer FQ, Wong-You-Cheong JJ. Imaging of acute pelvic pain. Clin Obstet Gynecol. Mar 2009;52(1):2-20. [Medline].

  17. Leiserowitz GS. Managing ovarian masses during pregnancy. Obstet Gynecol Surv. Jul 2006;61(7):463-70. [Medline].

  18. Grimes DA, Jones LB, Lopez LM, Schulz KF. Oral contraceptives for functional ovarian cysts. Cochrane Database Syst Rev. Apr 15 2009;CD006134. [Medline].

  19. Giuntoli RL 2nd, Vang RS, Bristow RE. Evaluation and management of adnexal masses during pregnancy. Clin Obstet Gynecol. Sep 2006;49(3):492-505. [Medline].

Previous
Next
 
Theca lutein cysts replacing an ovary in a patient with a molar pregnancy. Despite their size, these cysts are benign and usually resolve after treatment of the underlying disease.
A 24-cm diameter multilocular right ovarian cyst is seen with adjacent fallopian tube and uterus. The infundibulopelvic ligament carrying the ovarian artery and vein has been divided.
Transabdominal sonogram of the cyst in multimedia file 2 demonstrating a large, complex, cystic mass with septations. Color Doppler image shows vascularity within the septations. Red and blue colors show blood flow toward and away from the transducer. The resistive index was low. Histology reported a mucinous cystadenocarcinoma of low malignant potential. Courtesy of Patrick O'Kane, MD.
The cyst in multimedia files 2-3 has been removed and cut open. It has a smooth surface and a multicystic internal structure.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.